Corcept Therapeutics Incorporated (CORT)
Financial leverage ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Total assets | US$ in thousands | 840,553 | 621,517 | 583,430 | 423,756 | 571,731 |
| Total stockholders’ equity | US$ in thousands | 679,589 | 506,705 | 501,842 | 375,806 | 523,338 |
| Financial leverage ratio | 1.24 | 1.23 | 1.16 | 1.13 | 1.09 |
December 31, 2024 calculation
Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $840,553K ÷ $679,589K
= 1.24
The financial leverage ratio of Corcept Therapeutics Incorporated has shown a consistent upward trend over the years, increasing from 1.09 in December 2020 to 1.24 in December 2024. This indicates an increasing reliance on debt to finance the company's operations and investments. A higher financial leverage ratio may suggest higher financial risk as the company has more debt relative to its equity. It is important for stakeholders to closely monitor this trend to assess the company's ability to meet its debt obligations and manage its financial risks effectively.
Peer comparison
Dec 31, 2024